Sanuwave Health (NASDAQ:SNWV) Announces Earnings Results

Sanuwave Health (NASDAQ:SNWV) announced its quarterly earnings data on Thursday. The company reported $0.46 EPS for the quarter, FiscalAI reports. The business had revenue of $11.45 million during the quarter.

Sanuwave Health Stock Down 1.5%

NASDAQ SNWV traded down $0.40 during trading hours on Thursday, hitting $26.41. 168,998 shares of the company were exchanged, compared to its average volume of 64,607. Sanuwave Health has a 52 week low of $18.50 and a 52 week high of $46.58. The stock has a 50-day moving average price of $34.35 and a 200 day moving average price of $33.64. The stock has a market cap of $226.28 million, a PE ratio of -3.20 and a beta of 1.22.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Northland Capmk raised Sanuwave Health to a “strong-buy” rating in a report on Wednesday, September 3rd. Weiss Ratings reissued a “sell (d-)” rating on shares of Sanuwave Health in a report on Wednesday, October 8th. Roth Capital set a $53.00 target price on shares of Sanuwave Health and gave the stock a “buy” rating in a research report on Tuesday, October 7th. Wall Street Zen cut shares of Sanuwave Health from a “buy” rating to a “hold” rating in a research note on Saturday, October 11th. Finally, Northland Securities began coverage on shares of Sanuwave Health in a research note on Wednesday, September 3rd. They issued an “outperform” rating and a $55.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Sanuwave Health has a consensus rating of “Moderate Buy” and an average price target of $54.00.

Hedge Funds Weigh In On Sanuwave Health

Several large investors have recently modified their holdings of SNWV. Legal & General Group Plc purchased a new stake in Sanuwave Health during the 2nd quarter valued at $26,000. Strategic Investment Solutions Inc. IL bought a new position in Sanuwave Health during the first quarter valued at $47,000. BNP Paribas Financial Markets purchased a new stake in shares of Sanuwave Health in the second quarter valued at $46,000. Farther Finance Advisors LLC bought a new stake in shares of Sanuwave Health in the 3rd quarter worth about $57,000. Finally, Police & Firemen s Retirement System of New Jersey bought a new stake in shares of Sanuwave Health in the 2nd quarter worth about $52,000. Institutional investors own 42.53% of the company’s stock.

About Sanuwave Health

SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.